In this issue, we look into the future of two indications with high unmet need – amyotrophic lateral sclerosis (ALS) and nonalcoholic steatohepatitis (NASH)– through the lens of medical tech advances that aim to improve patients’ quality of life or accelerate the development of therapies via a less cumbersome method of diagnosis.

On the occasion of World IVF day, in another forward-looking analysis, we examine the assisted reproductive tech sector and the investment opportunities it presents.

Also in this issue, we dive into the latest trends in medical applications of nanotechnology.

Elsewhere, coinciding with the World Health Organization’s recent declaration of monkeypox as a global health emergency, we discuss new tests in development and how increased surveillance may drive this market. In a comment piece, Matt Barnes shares his vision for an IT network architecture fit for the NHS’ digital journey.

Keep reading for all the latest medical device industry news, comment, data and analysis from GlobalData.

Alvaro Arjona PhD, editor-in-chief